Cargando…
Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814136/ https://www.ncbi.nlm.nih.gov/pubmed/34757532 http://dx.doi.org/10.1007/s40744-021-00386-w |
| _version_ | 1784645002933043200 |
|---|---|
| author | Holman, Andrew J. Keystone, Edward Choy, Ernest Furst, Daniel Taylor, Peter Gaylis, Norman |
| author_facet | Holman, Andrew J. Keystone, Edward Choy, Ernest Furst, Daniel Taylor, Peter Gaylis, Norman |
| author_sort | Holman, Andrew J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8814136 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88141362022-02-10 Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19 Holman, Andrew J. Keystone, Edward Choy, Ernest Furst, Daniel Taylor, Peter Gaylis, Norman Rheumatol Ther Letter to the Editor Springer Healthcare 2021-11-10 /pmc/articles/PMC8814136/ /pubmed/34757532 http://dx.doi.org/10.1007/s40744-021-00386-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter to the Editor Holman, Andrew J. Keystone, Edward Choy, Ernest Furst, Daniel Taylor, Peter Gaylis, Norman Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19 |
| title | Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19 |
| title_full | Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19 |
| title_fullStr | Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19 |
| title_full_unstemmed | Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19 |
| title_short | Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19 |
| title_sort | considering immuno-autonomics in stratifying successful treatment of rheumatoid arthritis with tumor necrosis factor inhibition: comment on cohen et al. rheumatol ther 2021 june 19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814136/ https://www.ncbi.nlm.nih.gov/pubmed/34757532 http://dx.doi.org/10.1007/s40744-021-00386-w |
| work_keys_str_mv | AT holmanandrewj consideringimmunoautonomicsinstratifyingsuccessfultreatmentofrheumatoidarthritiswithtumornecrosisfactorinhibitioncommentoncohenetalrheumatolther2021june19 AT keystoneedward consideringimmunoautonomicsinstratifyingsuccessfultreatmentofrheumatoidarthritiswithtumornecrosisfactorinhibitioncommentoncohenetalrheumatolther2021june19 AT choyernest consideringimmunoautonomicsinstratifyingsuccessfultreatmentofrheumatoidarthritiswithtumornecrosisfactorinhibitioncommentoncohenetalrheumatolther2021june19 AT furstdaniel consideringimmunoautonomicsinstratifyingsuccessfultreatmentofrheumatoidarthritiswithtumornecrosisfactorinhibitioncommentoncohenetalrheumatolther2021june19 AT taylorpeter consideringimmunoautonomicsinstratifyingsuccessfultreatmentofrheumatoidarthritiswithtumornecrosisfactorinhibitioncommentoncohenetalrheumatolther2021june19 AT gaylisnorman consideringimmunoautonomicsinstratifyingsuccessfultreatmentofrheumatoidarthritiswithtumornecrosisfactorinhibitioncommentoncohenetalrheumatolther2021june19 |